THERAPEUTIC IMPLICATIONS OF ARACHIDONIC-ACID METABOLISM IN TRANSPLANT-ASSOCIATED ACUTE-RENAL-FAILURE

被引：7

作者：

BENNETT, WM

机构：

[1] Division of Nephrology, Hypertension and Clinical Pharmacology Oregon Health Sciences, University Portland, Oregon

来源：

RENAL FAILURE | 1992年 / 14卷 / 03期

关键词：

D O I：

10.3109/08860229209106628

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Acute renal failure is common in kidney transplantation due to immunologic, nephrotoxic, and ischemic events. In this paper the subject of posttransplant acute renal failure is reviewed in relation to arachidonic acid metabolism. Although experimental abnormalities noted in ischemia, rejection, and cyclosporin nephrotoxicity are discussed separately, it is obvious that in the clinical situation there is great overlap. The effects of altering the substrate arachidonic acid by feeding of dietary omega-3 fatty acids, both experimentally and clinically, are discussed. Finally, the limited clinical trials of prostaglandin analogues in renal transplant patients show conflicting conclusions as regards beneficial effects on rejection and renal function. Careful clinical studies of compounds with proven efficacy in animals are needed if acute renal failure posttransplant is to be modified or prevented.

引用

页码：261 / 265

页数：5

共 44 条

[1]

Halushka P.B., Lefer A.M., Thromboxane in health and disease, Fed Proc., 46, pp. 131-132, (1987)

[2]

Baylis C., Effects of administered thromboxane on the intact, normal rat kidney, Renal Physiol., 10, pp. 110-121, (1987)

[3]

Klausner J.M., Paterson I.S., Goldman G., Kobzik L., Rodzen C., Lawrence R., Valeria C.R., Shepro D., Hechtman H.B., Postischemic renal injury is mediated by neutrophils and leukotrienes, Am J Physiol., 256, pp. F794-F802, (1989)

[4]

Tate R.M., Morris H.G., Schroeder W.R., Repine J.E., Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline perfused rabbit lungs, J Clin Invest., 74, pp. 608-613, (1984)

[5]

Mullane K.M., Salmon J.A., Kraemer R., Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury, Fed Proc., 46, pp. 2422-2433, (1987)

[6]

Linas S.L., Shanley P.F., Whittenburg D., Berger E., Repine J.E., Neutrophils accentuate ischemia-reperfusion injury in isolated perfused rat kidneys, Am J Physiol., 255, pp. F728-F735, (1988)

[7]

Lelcuk S., Alexander F., Kobzik L., Valeri C.R., Shepro D., Hechtman H.B., Prostacyclin and thromboxane A2 moderates postischemic renal failure, Surgery, 98, pp. 207-212, (1985)

[8]

Loutzenhiser R., Epstein M., Horton C., Sonke P., Reversal of renal and smooth muscle actions of the thromboxane mimetic U-44069 by diltiazem, Am J Physiol., 250, pp. F619-F626, (1986)

[9]

Neumayer H.-H., Wagner K., Preuschof L., Stanke H., Shultze G., Molzahn M., Amelioration of postischemic acute renal failure by prostacyclin analogue (iloprost): Long-term studies with chronically instrumented conscious dogs, J Cardio Pharm., 8, pp. 785-790, (1986)

[10]

Coffman T.M., Yarger W.E., Klotman P.E., Functional role of throm-boxane production by rejecting renal allografts in rats, J Clin Invest., 75, pp. 1242-1249, (1985)

← 1 2 3 4 5 →